ASCO/NCCN publish guide for breast and colorectal cancer quality care

27 August 2006

The American Society of Clinical Oncology and the National Comprehensive Cancer Network have collaborated to develop seven evidence-based quality measures for breast and colorectal cancers. The ASCO/NCCN Quality Measures can be applied to assess the extent to which oncologists are providing quality care to their patients. The measures and their specifications are available on-line at www.asco.org/qualitymeasures and www.nccn.org.

They are appropriate for diverse measurement uses, including provider self-assessment, quality improvement programs and external quality monitoring. If appropriately implemented, the quality measures could serve as tools for future pay-for-reporting programs.

The Measures address processes of care that have been linked to patient outcomes, including survival, and apply to large numbers of cancer patients and target areas in which variation in care has been demonstrated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight